Dr. Xuguang Zhang is currently the Vice President of Mengniu Group and the Head of the Group's Nutrition and Health, R&D. He has previously served as the Executive Director of the Nutrition and Health Research Institute at ByHealth Co., Ltd.; Senior Scientist at the UK-listed company Provexis Plc (a company focused on drug and functional food ingredient R&D); Senior Scientist and New Product Development Manager at the UK-listed company Science in Sport Plc; and Senior Scientist and Nutritionist at the R&D headquarters of Fonterra Co-operative Group in New Zealand.

With over two decades of experience, Dr. Zhang has been dedicated to the innovation and R&D of functional ingredients, foods, and pharmaceuticals in areas such as cardiovascular health, metabolic health, gut health, infant nutrition, sports nutrition, and geriatric nutrition. While working as a researcher at the Rowett Institute of Nutrition and Health, University of Aberdeen, UK, he conducted research on systemic inflammation markers, interventions, and whey protein peptide functions in basic and clinical medicine. In 2010, Dr. Zhang led a UK research team in submitting and pioneering the EU-approved first nutrition and health claim: "Maintains normal platelet aggregation and normal blood flow health" (European Food Safety Authority, EFSA Regulation 13.5).